← FDA DRUG APPROVALS

FDA ANDA · ANDA208754

DOCOSANOL

Sponsor: P AND L

APPLICATION
ANDA208754
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-19
LATEST ACTION
2023-08-28
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Over-the-counter

Products

DOCOSANOLOver-the-counter
DOCOSANOL 10% · CREAM · TOPICAL

Approval history

2023-08-28Manufacturing (CMC) · Supplement 7AP
2018-11-19UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →